Literature DB >> 19298378

Pregnancy and rare bleeding disorders.

R Kadir1, C Chi, P Bolton-Maggs.   

Abstract

Rare bleeding disorders include deficiency of fibrinogen, prothrombin, factor V, factor VII, factor X, factor XI and factor XIII together with combined deficiency disorders, factor V+VIII deficiency, and deficiency of the vitamin K-dependent factors (factor II, VII, IX and X). They account for 3-5% of all inherited coagulation disorders. Due to their rarity, information about pregnancy complications and management is limited and mostly derived from case reports. Deficiency of fibrinogen and FXIII are both found to be strongly associated with increased risk of recurrent miscarriage and placental abruption. Factor replacement is used to reduce these risks. However, the risk of miscarriage and ante-partum complications is less clear in women with other bleeding disorders. Haemostatic abnormalities in women with rare bleeding disorders seem to persist throughout pregnancy especially if the defect is severe. Therefore women affected with these disorders are at risk of post-partum haemorrhage. The fetus can also be affected and potentially at risk of bleeding complications. Specialised multidisciplinary management is essential to minimise the potential maternal and neonatal complications and ensure an optimal outcome. This paper presents literature review for pregnancy complications in each of the rare bleeding disorders. In addition general principles for management of pregnancy, labour and delivery are discussed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19298378     DOI: 10.1111/j.1365-2516.2009.01984.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  11 in total

1.  Combined factor V and VIII deficiency and pregnancy.

Authors:  Bouchra Oukkache; Omar El Graoui; Saadia Zafad
Journal:  Int J Hematol       Date:  2012-10-17       Impact factor: 2.490

2.  Rare case of combined factor V and factor X deficiency in pregnancy: presenting as secondary postpartum haemorrhage in first pregnancy and successful outcome in second pregnancy.

Authors:  Aniket Kakade; Tushar Panchanadikar; Yashwant Kulkarni
Journal:  Obstet Med       Date:  2013-05-03

3.  Miscarriage and recurrent miscarriage in patients with congenital factor V deficiency: a report of six cases in Iran.

Authors:  Majid Naderi; Shadi Tabibian; Morteza Shamsizadeh; Akbar Dorgalaleh
Journal:  Int J Hematol       Date:  2016-03-15       Impact factor: 2.490

4.  The clinical management of factor XI deficiency in pregnant women.

Authors:  Allison P Wheeler; Celeste Hemingway; David Gailani
Journal:  Expert Rev Hematol       Date:  2020-06-12       Impact factor: 2.929

Review 5.  Is prophylaxis required for delivery in women with factor VII deficiency?

Authors:  L M Baumann Kreuziger; Colleen T Morton; Mark T Reding
Journal:  Haemophilia       Date:  2013-04-22       Impact factor: 4.287

Review 6.  Rare congenital bleeding disorders.

Authors:  Massimo Franchini; Giuseppe Marano; Simonetta Pupella; Stefania Vaglio; Francesca Masiello; Eva Veropalumbo; Vanessa Piccinini; Ilaria Pati; Liviana Catalano; Giancarlo Maria Liumbruno
Journal:  Ann Transl Med       Date:  2018-09

Review 7.  Update on inherited disorders of haemostasis and pregnancy.

Authors:  Orly Lavee; Giselle Kidson-Gerber
Journal:  Obstet Med       Date:  2016-01-20

8.  Management of pregnancy in a patient with severe hemophilia type a.

Authors:  Vipra Sharma; Aysha Khalid; Alice J Cohen
Journal:  AJP Rep       Date:  2012-12-31

9.  Successful Pregnancy in a Patient with Combined Deficiency of Factor V and Factor VIII.

Authors:  Ahmed Ghassan El Adib; Farah Majdi; Mohamed Othmane Dilai; Hamid Asmouki; Ahlam Bassir; Karam Harou; Abderraouf Soumani; Said Younous; Lahoucine Mahmal
Journal:  Case Rep Obstet Gynecol       Date:  2014-05-04

10.  Postpartum Hemorrhage in Heterozygote Factor XIII Deficient Women Compared With Healthy Women. A Cross-Sectional Experience From Iran.

Authors:  Majid Naderi; Ilia Mirzaei; Saeedeh Yaghoubi; Ida Milani; Nader Cohan
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.